It mediates biologic effects by binding to two cell-surface G protein-coupled receptors, IL-8RA (CXCR1) and IL-8RB (CXCR2), which are expressed on neutrophils, monocytes, endothelial cells, and cancer cells [1–4]. This evidence concerns the gene CXCR2 and cancer.